Apple Ordered to Pay $634 Million in Smartwatch Patent Dispute
Apple has been ordered to pay $634 million to Masimo, a medical technology company. This order comes after a jury found that Apple infringed on Masimo’s patents related to smartwatch technology. The case revolves around patents for measuring blood oxygen levels.
The verdict was delivered in a California federal court. Masimo accused Apple of using its technology without permission. This technology is used in Apple Watches to measure a user’s blood oxygen saturation.
The Patent Dispute
Masimo claims Apple hired its employees and stole its trade secrets. These secrets allegedly helped Apple develop the blood oxygen sensor in its smartwatches. Apple denies these allegations.
The lawsuit has been ongoing for several years. Masimo initially filed the suit in 2020. The company sought significant financial damages. The jury’s award of $634 million is less than Masimo originally requested, however, it is still a major win for the company.
Apple’s Response
Apple disagrees with the jury’s decision. The company plans to appeal the verdict. Apple believes its technology does not infringe on Masimo’s patents. They argue that their blood oxygen sensor was developed independently.
An Apple spokesperson stated they are considering all legal options. They intend to pursue further review of the case. This suggests Apple is prepared for a lengthy legal battle.
Impact on Apple Watch
This legal battle comes after Apple temporarily paused sales of its Series 9 and Ultra 2 watches. This pause was due to a separate patent dispute with another company, medical device maker, Masimo. That dispute involved the Apple Watch’s blood oxygen sensing technology as well. The sales have resumed after Apple made software changes.
What This Means for the Future
The outcome of Apple’s appeal could have significant implications for the smartwatch industry. It could affect how companies develop and protect their technology. Patent disputes in the tech world are common. However, this case highlights the importance of intellectual property rights.
In addition, it emphasizes the growing role of health-monitoring features in consumer electronics.
Meanwhile, Masimo is also pursuing a case against Apple at the International Trade Commission (ITC). They are seeking to block the import of Apple Watches that allegedly infringe on their patents.
In conclusion, the legal battle between Apple and Masimo is far from over. The final outcome will likely depend on the appeals process and the ITC’s decision.
Source: timesofindia.com
